As of 2026-04-07, the Relative Valuation of Sensei Biotherapeutics Inc (SNSE) is (362.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.38 USD, the upside of Sensei Biotherapeutics Inc based on Relative Valuation is -1186.7%.
The range of the Relative Valuation is (349.76) - (359.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 23.9x | 22.2x |
| Forward P/E multiples | 20.9x - 21.5x | 21.2x |
| Fair Price | (349.76) - (359.80) | (362.73) |
| Upside | -1147.8% - -1177.9% | -1186.7% |
| Date | P/E |
| 2026-04-06 | -1.99 |
| 2026-04-02 | -1.85 |
| 2026-04-01 | -2.08 |
| 2026-03-31 | -1.88 |
| 2026-03-30 | -1.50 |
| 2026-03-27 | -1.65 |
| 2026-03-26 | -1.61 |
| 2026-03-25 | -1.76 |
| 2026-03-24 | -1.79 |
| 2026-03-23 | -1.96 |
| 2026-03-20 | -1.89 |
| 2026-03-19 | -1.83 |
| 2026-03-18 | -1.82 |
| 2026-03-17 | -1.79 |
| 2026-03-16 | -1.79 |
| 2026-03-13 | -1.93 |
| 2026-03-12 | -1.86 |
| 2026-03-11 | -1.76 |
| 2026-03-10 | -1.79 |
| 2026-03-09 | -1.76 |
| 2026-03-06 | -1.79 |
| 2026-03-05 | -1.82 |
| 2026-03-04 | -1.88 |
| 2026-03-03 | -1.73 |
| 2026-03-02 | -1.78 |
| 2026-02-27 | -1.82 |
| 2026-02-26 | -1.81 |
| 2026-02-25 | -2.05 |
| 2026-02-24 | -2.10 |
| 2026-02-23 | -1.95 |
| 2026-02-20 | -2.00 |
| 2026-02-19 | -1.63 |
| 2026-02-18 | -1.57 |
| 2026-02-17 | -0.55 |
| 2026-02-13 | -0.54 |
| 2026-02-12 | -0.54 |
| 2026-02-11 | -0.53 |
| 2026-02-10 | -0.53 |
| 2026-02-09 | -0.53 |
| 2026-02-06 | -0.53 |
| 2026-02-05 | -0.53 |
| 2026-02-04 | -0.52 |
| 2026-02-03 | -0.54 |
| 2026-02-02 | -0.55 |
| 2026-01-30 | -0.57 |
| 2026-01-29 | -0.58 |
| 2026-01-28 | -0.60 |
| 2026-01-27 | -0.59 |
| 2026-01-26 | -0.61 |
| 2026-01-23 | -0.63 |